Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Receivables (2016 - 2025)

Historic Receivables for Healthstream (HSTM) over the last 16 years, with Q3 2025 value amounting to $33.7 million.

  • Healthstream's Receivables rose 645.91% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.7 million, marking a year-over-year increase of 645.91%. This contributed to the annual value of $35.3 million for FY2024, which is 812.57% down from last year.
  • Latest data reveals that Healthstream reported Receivables of $33.7 million as of Q3 2025, which was up 645.91% from $31.5 million recorded in Q2 2025.
  • Healthstream's 5-year Receivables high stood at $47.3 million for Q1 2023, and its period low was $30.7 million during Q3 2021.
  • In the last 5 years, Healthstream's Receivables had a median value of $35.3 million in 2024 and averaged $36.6 million.
  • In the last 5 years, Healthstream's Receivables tumbled by 2425.16% in 2021 and then skyrocketed by 2230.81% in 2022.
  • Quarter analysis of 5 years shows Healthstream's Receivables stood at $34.9 million in 2021, then grew by 22.31% to $42.7 million in 2022, then dropped by 9.98% to $38.4 million in 2023, then dropped by 8.13% to $35.3 million in 2024, then decreased by 4.53% to $33.7 million in 2025.
  • Its Receivables stands at $33.7 million for Q3 2025, versus $31.5 million for Q2 2025 and $36.1 million for Q1 2025.